UK life sciences ‘losing out’ to places such as Boston in the US
The UK needs to do more to improve its competitiveness with research centres such as Boston in the US, the Association of the British Pharmaceutical Industry has said, according to a Bloomberg report.
The ABPI says while the UK has lost pharma jobs, Boston has created new posts.
“The US has to be our benchmark. The UK has always been a great base of early science and discovery. We want to see more inward investment coming from the international players.”
Stephen Whitehead, chief executive, ABPI.
The ABPI has, alongside other bodies, published a review of the UK’s strategy to support life sciences, finding that eight out of the 13 initiatives in the strategy have “made notable progress” but that the “report provides an ‘honest assessment’ of the challenges and areas for further work“.
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.